Bariatric Surgery may worsen existing serious Diabetic Retinopathy: Study

Written By :  MD Bureau
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-01-22 05:15 GMT   |   Update On 2021-01-22 09:57 GMT

Morbid obesity is a major problem in developed societies; it is responsible for decreased expectancy and quality of life and leads to multiple comorbid conditions. Bariatric surgery is becoming increasingly popular with the rising prevalence of obesity.While bariatric surgery induces remission of type 2 diabetes mellitus and reduces other microvascular complications, its impact on...

Login or Register to read the full article

Morbid obesity is a major problem in developed societies; it is responsible for decreased expectancy and quality of life and leads to multiple comorbid conditions. Bariatric surgery is becoming increasingly popular with the rising prevalence of obesity.While bariatric surgery induces remission of type 2 diabetes mellitus and reduces other microvascular complications, its impact on diabetic retinopathy (DR) is unclear. 

Researchers have found in a new study that while bariatric surgery was associated with fewer cases of all and sight-threatening DR, early worsening was more severe in patients with existing sight-threatening DR.
The study findings were published in the American Journal of Ophthalmology on January 08, 2021.

Recently, bariatric surgery has been recognised not only as an effective treatment for achieving substantial sustained weight loss but also in inducing significant and rapid glycaemic control resulting in remission of type 2 diabetes in approximately 80% of cases within 2 years. Therefore, NICE has recommended bariatric surgery as a treatment option for obese patients with type 2 diabetes who are refractory to other weight-loss management options. However, little is known about the effect of bariatric surgery on diabetic microvascular complications such as diabetic retinopathy (DR). Some trials suggest early worsening of DR post-surgery due to rapid hyperglycemia improvements. Therefore, researchers of Ontario, Canada, conducted a meta-analysis to estimate the impact of bariatric surgery on DR for obese patients in comparison to medical treatment.

It was a systemic review and meta-analysis. Researchers used MEDLINE, EMBASE, and CENTRAL databases for primary studies comparing DR in patients undergoing bariatric surgery to medical management and included a total of 14 studies comprised of 110,300 surgical and 252,289 control patients. They used a random-effects model for the meta-analysis results. The major outcome assessed was the prevalence of all DR and sight-threatening DR after surgery. They also assessed the worsening of DR within and beyond 12 months.

Upon analysis, researchers noted that surgical patients had statistically significantly lower post-operative prevalence of all DR (RR 0.17) and sight-threatening DR (RR 0.47). They found early worsening of DR and progression to sight-threatening DR had occurred more often in those with more severe DR initially. They also found after 2 months, the bariatric surgery resulted in significantly fewer patients with worsened DR (RR 0.29). They reported that the overall risk of bias was low and the estimates of relative effects had low to moderate certainty of evidence.

The authors concluded, "While bariatric surgery was associated with fewer cases of all and sight-threatening DR, early worsening was more severe in patients with existing sight-threatening DR. These findings argue for frequent monitoring during the first post-operative year".

For further information:

https://www.ajo.com/article/S0002-9394(21)00007-6/fulltext#%20

Tags:    
Article Source :  American Journal of Ophthalmology

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News